Quick Answer
Sanara MedTech Inc. reported Cash and Equivalents of $16.58 million for fiscal year 2025.
Sanara MedTech Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $16.58M | +4.4% |
| 2024 | $15.88M | +208.5% |
| 2023 | $5.15M | -42.5% |
| 2022 | $8.96M | -52.0% |
| 2021 | $18.65M | +3996.2% |
| 2020 | $455.4K | -93.1% |
| 2019 | $6.61M | +3647.8% |
| 2018 | $176.4K | -61.9% |
| 2017 | $463.2K | -44.4% |
| 2016 | $833.5K | +357.1% |
| 2015 | $182.3K | -65.2% |
| 2014 | $523.4K | +1074.9% |
| 2013 | $44.6K | -2.9% |
| 2012 | $45.9K | +1171.1% |
| 2011 | $3.6K | -92.9% |
| 2010 | $50.8K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.94M | -8.2% | -11.9% |
| June 30, 2025 | $16.96M | +175.7% | -18.0% |
| March 31, 2025 | $20.69M | +631.5% | +30.3% |
| December 31, 2024 | $15.88M | +208.5% | -2.5% |
| September 30, 2024 | $16.28M | +161.0% | +164.7% |
| June 30, 2024 | $6.15M | +1.5% | +117.5% |
| March 31, 2024 | $2.83M | -61.2% | -45.1% |
| December 31, 2023 | $5.15M | -42.5% | -17.5% |
- Sanara MedTech Inc. showed an increase of +4.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2025 period, Sanara MedTech Inc.’s cash and equivalents has grown by 32513.1% (from $50.8 thousand to $16.58 million).
- The most recent figure is from Sanara MedTech Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: